CoChat

The Development of Molecular Biology of Osteoporosis

Open access
Gao, Yongguang, Patil, Suryaji, Jia, Jingxian · 2021 · International Journal of Molecular Sciences

The DOI matches its Crossref record; 164 of the 168 references it cites were found in a registry or an index.

Abstract

Osteoporosis is one of the major bone disorders that affects both women and men, and causes bone deterioration and bone strength. Bone remodeling maintains bone mass and mineral homeostasis through the balanced action of osteoblasts and osteoclasts, which are responsible for bone formation and bone resorption, respectively. The imbalance in bone remodeling is known to be the main cause of osteoporosis. The imbalance can be the result of the action of various molecules produced by one bone cell that acts on other bone cells and influence cell activity. The understanding of the effect of these molecules on bone can help identify new targets and therapeutics to prevent and treat bone disorders. In this article, we have focused on molecules that are produced by osteoblasts, osteocytes, and osteoclasts and their mechanism of action on these cells. We have also summarized the different pharmacological osteoporosis treatments that target different molecular aspects of these bone cells to minimize osteoporosis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/ijms22158182

Cites

164 of 164 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Cellular and molecular interplay during bone remodeling. M-CSF, RANKL produced by osteoblasts positively regulates while WNT5A/16 and OPG negatively regulates osteoclast function. SOST produced by osteocytes embedded in bone matrix positively and negatively regulates the osteoclast and osteoblast functions, respectively.
Figure 1 Cellular and molecular interplay during bone remodeling. M-CSF, RANKL produced by osteoblasts positively regulates while WNT5A/16 and OPG negatively regulates osteoclast function. SOST produced by osteocytes embedded in bone matrix positively and negatively regulates the osteoclast and osteoblast functions, respectively.CC BY · PubMed Central
Figure 2 Molecules responsible for osteoblast differentiation. The commitment of mesenchymal stem cells to osteogenic progenitor cells is influenced by Runx2, FGF, Wnt, as well as MITF and SATB2, while Osx, Runx2, NFATc1 promote osteogenic progenitor cell proliferation to preosteoblasts, which is then muture into mature and functional osteoblasts by the action of Runx2, FGF, Wnt, NFATc1, MITF as well as ATF4.
Figure 2 Molecules responsible for osteoblast differentiation. The commitment of mesenchymal stem cells to osteogenic progenitor cells is influenced by Runx2, FGF, Wnt, as well as MITF and SATB2, while Osx, Runx2, NFATc1 promote osteogenic progenitor cell proliferation to preosteoblasts, which is then muture into mature and functional osteoblasts by the action of Runx2, FGF, Wnt, NFATc1, MITF as well as ATF4.CC BY · PubMed Central
Figure 3 Molecules involved in the process of osteoclast differentiation. M-CSF/c-Fms, MITF, and PU.1 promote differentiation of myeloid precursors into osteoclasts precursor which fuse together to form immature osteoclasts. The maturation of immature osteoclasts to mature osteoclasts is facilitated by integrin-β3 and CatK.
Figure 3 Molecules involved in the process of osteoclast differentiation. M-CSF/c-Fms, MITF, and PU.1 promote differentiation of myeloid precursors into osteoclasts precursor which fuse together to form immature osteoclasts. The maturation of immature osteoclasts to mature osteoclasts is facilitated by integrin-β3 and CatK.CC BY · PubMed Central
Figure 4 The mechanism of action of osteoporosis therapeutics. The antiresorptive drugs such as bisphosphonate (BP), estrogen, anti-RANKLs (denosumab) and calcitonin; anabolic drugs such as PTH and anti-sclerostins (romosozumab) affecting different bone cells. + mean positive effect; − mean negative effect [10].
Figure 4 The mechanism of action of osteoporosis therapeutics. The antiresorptive drugs such as bisphosphonate (BP), estrogen, anti-RANKLs (denosumab) and calcitonin; anabolic drugs such as PTH and anti-sclerostins (romosozumab) affecting different bone cells. + mean positive effect; − mean negative effect [10].CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 116

Metadata

Authors
Gao, Y., Patil, S., & Jia, J.
Affiliations
  • Tangshan Normal University (CN)
  • Northwestern Polytechnical University (CN)
Corresponding author
Gao, Yongguang
Venue
International Journal of Molecular Sciences
Publisher
MDPI AG
Published
2021-07-30
Volume
22
Issue
15
Pages
8182
ISSN
1422-0067 (ISSN-L)
OpenAlex
W3191096784
Cited by
116
References
168
Citations by year
2026: 9 · 2025: 27 · 2024: 33 · 2023: 22 · 2022: 18 · 2021: 6
FWCI
2.07
Type
journal article
Language
en
Open access
Locations
  • International Journal of Molecular Sciences (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Natural Science Foundation of Hebei Province (2021105001)
  • Key project for scientific research in colleges and universities of Hebei province (ZD2021408)
  • Scientific Research Foundation of Tangshan normal university (2021A03)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
  • Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Bone and Dental Protein Studies
Keywords
osteoporosis, bone remodeling, osteoblasts, osteoclasts, osteocytes, bone resorption, bone formation, bone mineral homeostasis, paracrine signaling, bone disease
MeSH terms
Calcium-Regulating Hormones and Agents, Animals, Humans, Osteoclasts, Osteoporosis, Bone Remodeling, Bone Density Conservation Agents

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.